Mycothiol Biosynthesis and Metabolic Functions

菌硫醇生物合成和代谢功能

基本信息

  • 批准号:
    0235705
  • 负责人:
  • 金额:
    $ 37.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

Mycothiol (MSH, AcCys-GlcN-Ins), is the major low-molecular-weight thiol produced by actinomycetes, a broad group of gram positive bacteria which include the streptomycetes and mycobacteria. Current evidence indicates that MSH has functions in actinomycetes analogous to glutathione (GSH) in GSH-producing organisms but our understanding of MSH biochemistry is still limited. The four enzymes involved in MSH biosynthesis and one enzyme involved in a novel MSH-dependent detoxification pathway have been identified in this laboratory. Mycobacterial mutants have also been obtained which are blocked at various steps of MSH biosynthesis. The present studies continue the elucidation of the metabolic biochemistry of mycothiol. The regulation of MSH biosynthesis will be examined through kinetic studies with the final two enzymes of MSH biosynthesis, MshC and MshD, and through gene replacement studies to test the role of putative MSH regulatory genes. The importance of MSH and its biosynthetic intermediates for mycobacterial sensitivity to toxins and antibiotics will be determined through studies of MSH deficient mutants blocked at various steps of MSH production. The role of MSH in the detoxification of the antibiotic rifamycin will be examined using radioactive labeling of MSH in Mycobacterium smegmatis to permit identification of MSH adducts and degradation products, and through kinetic studies of MSH-rifamycin adduct metabolism by the degradative enzyme mycothiol S-conjugate amidase.A novel antioxidant named mycothiol has been found to be produced by a class of bacteria which include the streptomycetes, the main antibiotic-producing bacteria, and the mycobacteria, the causative agents of tuberculosis and leprosy. Evidence indicates that mycothiol is involved in protecting cells against various toxins and antibiotics. This research will elucidate the factors involved in regulating mycothiol production in mycobacteria and the role of mycothiol in detoxifying the antibiotic rifamycin. The results could provide the basis for devising methods to enhance the ability of bacteria to detoxify environmental pollutants (bioremediation) and for increasing antibiotic production in streptomycete fermentations.
霉硫醇(Mycothiol,MSH,AcCys-GlcN-ins)是放线菌产生的主要低分子硫醇,是包括链霉菌和分枝杆菌在内的一大类革兰氏阳性细菌。目前的证据表明,MSH在放线菌中具有类似于谷胱甘肽(GSH)的功能,但我们对MSH生物化学的了解仍然有限。本实验室已鉴定了参与MSH生物合成的四种酶和参与MSH依赖的新解毒途径的一种酶。还获得了分枝杆菌突变体,它们在MSH生物合成的各个步骤中被阻断。本研究继续阐明了霉菌硫醇的代谢生化。MSH生物合成的调控将通过MSH生物合成的最后两种酶MSHC和MshD的动力学研究以及通过基因替换研究来测试假定的MSH调节基因的作用。MSH及其生物合成中间体对分枝杆菌对毒素和抗生素敏感性的重要性将通过对MSH缺陷突变株的研究来确定,这些突变株被阻止在MSH生产的各个步骤。通过对污垢分枝杆菌中MSH的放射性标记以鉴定MSH加合物和降解产物,以及通过降解酶霉硫醇S偶联酰胺酶对MSH-利福霉素加合物代谢的动力学研究,将考察MSH在抗生素利福霉素解毒中的作用。已发现一种名为霉硫醇的新型抗氧化剂是由一类细菌产生的,其中包括主要产生抗生素的链霉菌和引起结核病和麻风的分枝杆菌。有证据表明,霉菌硫醇参与保护细胞免受各种毒素和抗生素的伤害。这项研究将阐明分枝杆菌中参与调节分枝杆菌产生分枝杆菌硫醇的因素,以及分枝杆菌硫醇在解毒抗生素利福霉素中的作用。研究结果可为设计提高细菌解毒环境污染物能力的方法(生物修复)和提高链霉菌发酵中抗生素的产量提供依据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Fahey其他文献

Robert Fahey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Fahey', 18)}}的其他基金

Rapid: Assessing Temporal Dynamics of Disturbance Interactions as a Driver of a Novel Forest Mortality Event
快速:评估干扰相互作用的时间动态作为新型森林死亡事件的驱动因素
  • 批准号:
    1917705
  • 财政年份:
    2019
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
Collaborative Research: MSA: Incorporating Canopy Structural Complexity to Improve Model Forecasts of Functional Effects of Forest Disturbance
合作研究:MSA:结合冠层结构复杂性来改进森林扰动功能效应的模型预测
  • 批准号:
    1926442
  • 财政年份:
    2019
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
Collaborative Research: EAGER-NEON: Is Canopy Structural Complexity a Global Predictor of Primary Production?: Using NEON to Transform Understanding of Forest Structure-function
合作研究:EAGER-NEON:树冠结构复杂性是初级生产的全球预测因子吗?:利用 NEON 转变对森林结构功能的理解
  • 批准号:
    1550650
  • 财政年份:
    2015
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
Collaborative Research: EAGER-NEON: Is Canopy Structural Complexity a Global Predictor of Primary Production?: Using NEON to Transform Understanding of Forest Structure-function
合作研究:EAGER-NEON:树冠结构复杂性是初级生产的全球预测因子吗?:利用 NEON 转变对森林结构功能的理解
  • 批准号:
    1560944
  • 财政年份:
    2015
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
The Ligase and Acetyltransferase Enzymes of Mycothiol Biosynthesis
菌硫醇生物合成的连接酶和乙酰转移酶
  • 批准号:
    9981850
  • 财政年份:
    2000
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Continuing Grant
Conformational Equilibria in Acyclic Molecules
无环分子的构象平衡
  • 批准号:
    7002005
  • 财政年份:
    1970
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant

相似海外基金

RUI: BIOPOLYMER - BIObricks POLYketide Metabolic EngineeRing platform for unraveling the biosynthesis of higher anthracyclines
RUI:BIOPOLYMER - BIObricks 聚酮化合物代谢工程平台,用于揭示高级蒽环类药物的生物合成
  • 批准号:
    2321976
  • 财政年份:
    2024
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
PlantSynBio: Integrate Natural Product Biosynthesis into the Global Metabolic Network
PlantSynBio:将天然产物生物合成整合到全球代谢网络中
  • 批准号:
    2313322
  • 财政年份:
    2023
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Standard Grant
The Discovery of Novel Metabolic Pathways for the Biosynthesis and Degradation of Complex Carbohydrates within the Human Gut Microbiome
人类肠道微生物组内复杂碳水化合物生物合成和降解的新代谢途径的发现
  • 批准号:
    10323657
  • 财政年份:
    2021
  • 资助金额:
    $ 37.45万
  • 项目类别:
The Discovery of Novel Metabolic Pathways for the Biosynthesis and Degradation of Complex Carbohydrates within the Human Gut Microbiome
人类肠道微生物组内复杂碳水化合物生物合成和降解的新代谢途径的发现
  • 批准号:
    10557076
  • 财政年份:
    2021
  • 资助金额:
    $ 37.45万
  • 项目类别:
The Discovery of Novel Metabolic Pathways for the Biosynthesis and Degradation of Complex Carbohydrates within the Human Gut Microbiome
人类肠道微生物组内复杂碳水化合物生物合成和降解的新代谢途径的发现
  • 批准号:
    10084621
  • 财政年份:
    2021
  • 资助金额:
    $ 37.45万
  • 项目类别:
Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
  • 批准号:
    10408034
  • 财政年份:
    2020
  • 资助金额:
    $ 37.45万
  • 项目类别:
Microbial metabolic engineering for cannabinoid biosynthesis
大麻素生物合成的微生物代谢工程
  • 批准号:
    522967-2017
  • 财政年份:
    2020
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Collaborative Research and Development Grants
Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
  • 批准号:
    10202652
  • 财政年份:
    2020
  • 资助金额:
    $ 37.45万
  • 项目类别:
Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
  • 批准号:
    10629363
  • 财政年份:
    2020
  • 资助金额:
    $ 37.45万
  • 项目类别:
Development and application of novel screening and selection strategies for the enzyme- and metabolic engineering of alkane biosynthesis
烷烃生物合成酶和代谢工程的新型筛选和选择策略的开发和应用
  • 批准号:
    2271305
  • 财政年份:
    2019
  • 资助金额:
    $ 37.45万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了